March 04, 2015 1:53 PM ET

Biotechnology

Company Overview of CellAct Pharma GmbH

Company Overview

CellAct Pharma GmbH, a biotechnology company, engages in the development of therapeutics for the treatment of cancers and inflammatory diseases. The company develops drug candidates that target and modulate human molecules which have specific functions in tumour growth and immune response; and antibodies against surface molecules in lymphocytes to treat cancer and inflammation. It focuses on developing drugs for various diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, transplant rejection, lymphomas, and leukemia. CellAct Pharma GmbH is based in Dortmund, Germany.

BioMedizinZentrum

Otto-Hahn-Str. 15

Dortmund,  44227

Germany

Phone:

49 23197426350

Fax:

49 23197426355

Key Executives for CellAct Pharma GmbH

Co-Founder and Managing Director of Business Affairs
Age: 47
Co-Founder and Managing Director of Research & Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Source BioScience imaGenes Europe
InoCard GmbH Europe
Pro-tec Medizinische Produkte GmbH Europe
Cilian AG Europe
ALVITO Biotechnologie GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CellAct Pharma GmbH, please visit www.cellact.eu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.